Cargando…

Quality of life and depression in patients with amyotrophic lateral sclerosis – does the country of origin matter?

BACKGROUND: Given the inevitable relentless progressing nature of amyotrophic lateral sclerosis (ALS), it is essential to identify factors influencing patients’ wellbeing. The study aimed to prospectively assess factors influencing the quality of life (QoL) and depression in ALS patients compared to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ciećwierska, Katarzyna, Lulé, Dorothée, Bielecki, Maksymilian, Helczyk, Olga, Maksymowicz-Śliwińska, Anna, Finsel, Julia, Nieporęcki, Krzysztof, Andersen, Peter M., Ludolph, Albert C., Kuźma-Kozakiewicz, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10262126/ https://www.ncbi.nlm.nih.gov/pubmed/37312136 http://dx.doi.org/10.1186/s12904-023-01189-2

Ejemplares similares

Religiosity in patients with amyotrophic lateral sclerosis, a cross-country comparison
por: Ciećwierska, Katarzyna, et al.
Publicado: (2023)

Well‐being on supportive techniques in amyotrophic lateral sclerosis: from neurologists' perspective
por: Barć, Krzysztof, et al.
Publicado: (2022)

An observational study on quality of life and preferences to sustain life in locked-in state
por: Kuzma-Kozakiewicz, Magdalena, et al.
Publicado: (2019)

Neuropsychological deficits have only limited impact on psychological well-being in amyotrophic lateral sclerosis
por: Schrempf, Till, et al.
Publicado: (2021)

Emotional Lability at Disease Onset Is an Independent Prognostic Factor of Faster Disease Progression in Amyotrophic Lateral Sclerosis
por: Barć, Krzysztof, et al.
Publicado: (2020)

Saccadic intrusions in amyotrophic lateral sclerosis (ALS)
por: Becker, Wolfgang, et al.
Publicado: (2019)

Ethical Principles in Patient-Centered Medical Care to Support Quality of Life in Amyotrophic Lateral Sclerosis
por: Lulé, Dorothée, et al.
Publicado: (2019)

SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity
por: Berdyński, Mariusz, et al.
Publicado: (2022)

Existential decision-making in a fatal progressive disease: how much do legal and medical frameworks matter?
por: Weber, Christian, et al.
Publicado: (2017)

Does the MUNIX Method Reflect Clinical Dysfunction in Amyotrophic Lateral Sclerosis: A Practical Experience
por: Gawel, Malgorzata, et al.
Publicado: (2016)

Validation of qPCR reference genes in lymphocytes from patients with amyotrophic lateral sclerosis
por: Usarek, Ewa, et al.
Publicado: (2017)

Multimodal in vivo staging in amyotrophic lateral sclerosis using artificial intelligence
por: Behler, Anna, et al.
Publicado: (2022)

Longitudinal monitoring of amyotrophic lateral sclerosis by diffusion tensor imaging: Power calculations for group studies
por: Behler, Anna, et al.
Publicado: (2022)

A multivariate Bayesian classification algorithm for cerebral stage prediction by diffusion tensor imaging in amyotrophic lateral sclerosis
por: Behler, Anna, et al.
Publicado: (2022)

Potential Preventive Strategies for Amyotrophic Lateral Sclerosis
por: Kuraszkiewicz, B., et al.
Publicado: (2020)

Functional connectivity changes resemble patterns of pTDP-43 pathology in amyotrophic lateral sclerosis
por: Schulthess, Ines, et al.
Publicado: (2016)

Imaging the pathoanatomy of amyotrophic lateral sclerosis in vivo: targeting a propagation-based biological marker
por: Kassubek, Jan, et al.
Publicado: (2018)

Umbilical Cord Mesenchymal Stem Cells in Amyotrophic Lateral Sclerosis: an Original Study
por: Barczewska, Monika, et al.
Publicado: (2020)

Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosis
por: Häggmark, Anna, et al.
Publicado: (2014)

Perception of Emotional Facial Expressions in Amyotrophic Lateral Sclerosis (ALS) at Behavioural and Brain Metabolic Level
por: Aho-Özhan, Helena E. A., et al.
Publicado: (2016)

Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS Population
por: Korner, Sonja, et al.
Publicado: (2019)

The use of P300-based BCIs in amyotrophic lateral sclerosis: from augmentative and alternative communication to cognitive assessment
por: Cipresso, Pietro, et al.
Publicado: (2012)

Repeat Administration of Bone Marrow-Derived Mesenchymal Stem Cells for Treatment of Amyotrophic Lateral Sclerosis
por: Siwek, Tomasz, et al.
Publicado: (2020)

Non-invasive ventilation in amyotrophic lateral sclerosis
por: Dorst, Johannes, et al.
Publicado: (2019)

COMPLEX TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS PATIENT
por: Białkowska, Joanna, et al.
Publicado: (2019)

Trends in the diagnostic delay and pathway for amyotrophic lateral sclerosis patients across different countries
por: Falcão de Campos, Catarina, et al.
Publicado: (2023)

Eye Movement Deficits Are Consistent with a Staging Model of pTDP-43 Pathology in Amyotrophic Lateral Sclerosis
por: Gorges, Martin, et al.
Publicado: (2015)

Safety of intrathecal injection of Wharton’s jelly-derived mesenchymal stem cells in amyotrophic lateral sclerosis therapy
por: Barczewska, Monika, et al.
Publicado: (2019)

Cognitive Performance of Patients with Adult 5q-Spinal Muscular Atrophy and with Amyotrophic Lateral Sclerosis
por: Osmanovic, Alma, et al.
Publicado: (2020)

Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis
por: Dorst, Johannes, et al.
Publicado: (2017)

Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis
por: Volk, Alexander E., et al.
Publicado: (2018)

Skeletal muscle in amyotrophic lateral sclerosis
por: Shefner, Jeremy M, et al.
Publicado: (2023)

The Fragile X Protein Family in Amyotrophic Lateral Sclerosis
por: Mueller, Sarah, et al.
Publicado: (2023)

Analysis of routine blood parameters in patients with amyotrophic lateral sclerosis and evaluation of a possible correlation with disease progression—a multicenter study
por: Hertel, Nora, et al.
Publicado: (2022)

Synapse loss in the prefrontal cortex is associated with cognitive decline in amyotrophic lateral sclerosis
por: Henstridge, Christopher M., et al.
Publicado: (2017)

CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
por: Kruminis-Kaszkiel, Ewa, et al.
Publicado: (2018)

ROCK-ALS: Protocol for a Randomized, Placebo-Controlled, Double-Blind Phase IIa Trial of Safety, Tolerability and Efficacy of the Rho Kinase (ROCK) Inhibitor Fasudil in Amyotrophic Lateral Sclerosis
por: Lingor, Paul, et al.
Publicado: (2019)

Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis
por: Lindauer, Eva, et al.
Publicado: (2013)

The Role of Glia in Canine Degenerative Myelopathy: Relevance to Human Amyotrophic Lateral Sclerosis
por: Golubczyk, Dominika, et al.
Publicado: (2019)

Overcoming therapeutic nihilism. Breaking bad news of amyotrophic lateral sclerosis—a patient-centred perspective in rare diseases
por: Maksymowicz, Stanisław, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n6u7hsncnlp01m2258sna4coqm